These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 33922658)

  • 21. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.
    Torres-Aguilar H; Aguilar-Ruiz SR; González-Pérez G; Munguía R; Bajaña S; Meraz-Ríos MA; Sánchez-Torres C
    J Immunol; 2010 Feb; 184(4):1765-75. PubMed ID: 20083662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerogenic dendritic cells: cytokine modulation comes of age.
    Rutella S; Danese S; Leone G
    Blood; 2006 Sep; 108(5):1435-40. PubMed ID: 16684955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity.
    Passeri L; Marta F; Bassi V; Gregori S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cells: vehicles for tolerance induction and prevention of autoimmune diseases.
    van Duivenvoorde LM; van Mierlo GJ; Boonman ZF; Toes RE
    Immunobiology; 2006; 211(6-8):627-32. PubMed ID: 16920501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases.
    Mackern-Oberti JP; Llanos C; Vega F; Salazar-Onfray F; Riedel CA; Bueno SM; Kalergis AM
    Autoimmun Rev; 2015 Feb; 14(2):127-39. PubMed ID: 25449681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cells: cellular mediators for immunological tolerance.
    Chung CY; Ysebaert D; Berneman ZN; Cools N
    Clin Dev Immunol; 2013; 2013():972865. PubMed ID: 23762100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting DCs for Tolerance Induction: Don't Lose Sight of the Neutrophils.
    Hafkamp FMJ; Groot Kormelink T; de Jong EC
    Front Immunol; 2021; 12():732992. PubMed ID: 34675923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.
    Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M
    Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
    Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
    Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
    Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerogenic dendritic cells induced the enrichment of CD4
    Jia L; Lu J; Zhou Y; Tao Y; Xu H; Zheng W; Zhao J; Liang G; Xu L
    Clin Immunol; 2018 Dec; 197():118-129. PubMed ID: 30248398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Importance of Dendritic Cells in Maintaining Immune Tolerance.
    Audiger C; Rahman MJ; Yun TJ; Tarbell KV; Lesage S
    J Immunol; 2017 Mar; 198(6):2223-2231. PubMed ID: 28264998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasone.
    Lee JH; Park CS; Jang S; Kim JW; Kim SH; Song S; Kim K; Lee CK
    Sci Rep; 2017 Nov; 7(1):15087. PubMed ID: 29118423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI.
    Torres-Aguilar H; Blank M; Kivity S; Misgav M; Luboshitz J; Pierangeli SS; Shoenfeld Y
    Ann Rheum Dis; 2012 Jan; 71(1):120-8. PubMed ID: 21914629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells.
    Matsumura Y; Kobayashi T; Ichiyama K; Yoshida R; Hashimoto M; Takimoto T; Tanaka K; Chinen T; Shichita T; Wyss-Coray T; Sato K; Yoshimura A
    J Immunol; 2007 Aug; 179(4):2170-9. PubMed ID: 17675476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction.
    Morelli AE; Thomson AW
    Immunol Rev; 2003 Dec; 196():125-46. PubMed ID: 14617202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells generated in the presence of interferon-α and modulated with dexamethasone as a novel tolerogenic vaccine platform.
    Leplina O; Kurochkina Y; Tikhonova M; Shevela E; Ostanin A; Chernykh E
    Inflammopharmacology; 2020 Feb; 28(1):311-319. PubMed ID: 31552546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designer dendritic cells for tolerance induction: guided not misguided missiles.
    Hackstein H; Morelli AE; Thomson AW
    Trends Immunol; 2001 Aug; 22(8):437-42. PubMed ID: 11473833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
    van Kooten C; Stax AS; Woltman AM; Gelderman KA
    Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cells as gatekeepers of tolerance.
    Waisman A; Lukas D; Clausen BE; Yogev N
    Semin Immunopathol; 2017 Feb; 39(2):153-163. PubMed ID: 27456849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.